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Abstract: A long circulating liposomal, nanoscale blood pool agent encapsulating traditional 
iodinated contrast agent (65 mg I/mL) was used for micro-computed tomography (CT) imaging 
of rats implanted with R3230AC mammary carcinoma. Three-dimensional vascular architec-
ture of tumors was imaged at 100-micron isotropic resolution. The image data showed good 
qualitative correlation with pathologic findings. The approach holds promise for studying tumor 
angiogenesis and for evaluating anti-angiogenesis therapies.
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Introduction
Angiogenesis plays an important role in breast tumor growth and in the process of 
metastasis.1 However, imaging angiogenesis using X-ray-based techniques has proved 
extremely difficult due to the small amount of contrast enhancement and the limited 
size of the tumor vessels. To surmount these difficulties, several conditions need to 
be met: a high concentration of contrast agent to provide adequate imaging signal, 
a stable contrast enhancement during the imaging procedure, and an imaging system 
with high spatial, contrast, and temporal resolution.
In the past few years, liposomes have been studied as excellent vehicles for drug 
delivery.2–7 They have also been used as contrast agents in computed tomography (CT) 
and magnetic resonance (MR) imaging,8–10 and as a delivery mechanism of contrast 
molecules to tumor regions.11 Some members of this group have previously devel-
oped and evaluated a long circulating liposomal-based, nanoparticle contrast agent 
for blood pool imaging.10 The agent has longer in vivo residence time than traditional 
contrast agents. The hypothesis of this study was that this new contrast agent would 
have utility in breast cancer imaging, providing long-lasting opacification of tumor 
microvasculature in micro-CT images of rats with implanted mammary tumors. The 
purpose of the study was to perform a proof-of-principle imaging experiment with 
this contrast agent by obtaining high-resolution images of mammary tumors in the rat 
model and qualitatively compare the images to histological specimens.
Materials and methods
contrast agent formation
A lipid mixture (200 mM) consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC), cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (DSPE-MPEG2000) in the molar ratio 55:40:5 International Journal of Nanomedicine 2009:4 278
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was dissolved in ethanol at 70 °C. The ethanol solution was 
then hydrated for two hours with Iopamidol solution (Isovue® 
370, Bracco Diagnostics, Princeton, NJ, USA). Liposomes 
were extruded in a 10-mL Lipex Thermoline extruder 
(Northern Lipids, Vancouver, British Columbia, Canada) with 
five passes and seven passes, respectively, through a 200- and 
a 100-nm Nuclepore membrane (Waterman, Newton, MA). 
Un-encapsulated iodine was then removed with a MicroKros® 
filtration module (Spectrum Labs, Rancho Dominguez, CA, 
USA) with a 400-kDa cut-off. Further detail on this synthesis 
process can be found in an earlier publication.10
The size distribution of the liposomes in the final 
formulation was determined by dynamic light scattering 
using a ZetaPlus Analyzer (Brookhaven Instruments, Inc., 
Chapel House, UK). The resultant liposomes were found 
to be 113 nm in size with a polydispersity index of 0.14. 
The iodine concentration in the liposomal formulations was 
65 ± 5 mg/ml, assessed based on the absorption of ultraviolet 
light at 242 nm measured with an ultraviolet-visible light 
spectrophotometer.
In vivo studies
All animal procedures were performed using protocols 
approved by the Duke University Institutional Animal Care 
and Use Committee. Eight female Fischer 344 rats (National 
Cancer Institute, Frederick Cancer Center, Frederick, MD, 
USA) with a weight of 126.6–145.5 g (140 g average) 
were used for the study. Each rat was implanted with the 
R3230AC Rat Mammary Adenocarcinoma.12 For tumor 
implantation, small pieces of tumor tissue (1–2 mm3) were 
obtained from tumor-bearing donor rats and transplanted 
subcutaneously in the right flank of each recipient animal. 
The animals were imaged approximately three weeks 
after implantation when the tumors reached 1–1.5 cm in 
diameter. They were imaged twice; at one and four hours 
after contrast injection.
Animal procedures
The rats were anesthetized using an intra-peritoneal 50 mg/kg 
injection of sodium pentobarbital and 2 mg/kg butorphanol. 
Following endotracheal intubation, anesthesia was maintained 
with 2%–3% isoflurane, delivered by a custom-made 
ventilator.13 Animals were mechanically ventilated at 
90 breaths/min and at a tidal volume of 1.0 ml.
The iodinated liposomes were delivered via injection 
into a microcatheter inserted into the tail vein at a volume 
dose of approximately 0.02 ml/kg of animal weight. This 
was chosen as a standard volume for infusion as it results in 
adequate opacification of the blood vessels and tumors, and 
was well tolerated by the animals.
Animals were placed vertically in a cradle. Flexible tubes 
carrying anesthesia gas and wires conveying physiologic 
telemetric signals were suspended from above to allow free 
rotation of the animal throughout the 190° rotation (Figure 1). 
All physiological telemetry data were displayed on a computer 
(LabVIEW, National Instruments, Austin, TX, USA). The 
monitored physiologic parameters were airway pressure 
tracing, measured with a solid-state pressure transducer on the 
breathing valve, and ECG, measured by electrodes taped to 
the footpads. Body temperature was maintained at 36.5 °C 
with heat lamps, an oral thermistor, and feedback controller 
(Digi-Sense®, Cole-Parmer, Chicago, IL, USA).
Following the study, the animals were euthanized with 
an overdose of nembutal. Tumors were excised, sectioned 
into 5 to 10 micron slices, and stained using hematoxilin and 
eosin (H&E) staining. Histological analysis was performed 
on the stained slices.
Micro-cT system
The micro-CT system used, described previously14 consisted 
of a high-flux, rotating anode X-ray tube (Philips SRO 09 50, 
Cleveland, OH, USA) with a dual 0.3/1.0-mm focal spot. The 
tube was capable of 10 msec exposures to minimize cardiac 
motion blur. The tube was coupled to a cooled charge-coupled 
device (CCD) camera with a Gd2O2S phosphor on a fiber-
optic coupler with 3:1 de-magnification ratio (X-ray Image-
Star, Photonics Science, East Sussex, UK). The camera had 
a 106 mm2 active field-of-view with a pixel size of 51 µm. 
The tube and detector were mounted in the horizontal plane 
on aluminum frame components (80/20 Inc., Columbia City, 
IN, USA) (see Figure 1).
The animal was centered vertically at 40 mm from the 
detector face. The distance between the animal and X-ray 
source was 480 mm. This configuration essentially eliminated 
scatter, and focal spot blur by matching the penumbra to the 
Nyquist limiting frequency of the detector.14,15
Image acquisition and reconstruction
Animals were imaged using 40 kVp, 400 mA, and 12.5 msec 
exposure time. This low-kVp radiographic technique was 
chosen to enhance soft-tissue contrast within the animal. Each 
image set consisted of 380 projections regularly spaced over 
a circular orbit of 190°. Each dataset acquisition per animal 
lasted for 8–10 minutes and led to an average absorbed dose 
of 27 cGy. All projections were acquired with ventilatory 
synchronization at end-expiration. Projection images were International Journal of Nanomedicine 2009:4 279
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used to reconstruct tomograms with a Feldkamp algorithm 
using Parker weighting (Cobra EXXIM, EXXIM Computing 
Corp., Livermore, CA). The reconstructed datasets were 3D 
image arrays 5.12 cm3 in size with (0.1 mm)3 voxels.
Contrast enhancement was measured in regions of interest 
(ROIs) in the tumor as well as in the muscle. To tumor ROI 
was confined to within a vascular enhancement region 
within each tumor. The muscle region was approximately 
5 × 5 mm chosen on the contra-lateral flank of the animal. 
Tumor volumes and characteristics were obtained by hand 
segmentation using ImageJ software (http://rsb.info.nih.
gov/ij/). Qualitative comparison was made of microvessel 
distribution, and regions of necrosis between CT images and 
corresponding histological sections.
Results
The liposomal contrast agent produced an average CT 
number of 861 ± 180 HU (mean ± standard deviation) in 
tumor vasculature and 535 ± 113 HU in muscle, for an aver-
age contrast difference of 326 ± 151 HU. Within the tumor, 
vessels as small as 200–300 microns were readily visible. 
The average tumor volume determined by hand segmenta-
tion was 0.52 ± 0.12 cm3. Enhancement, presumably of the 
microvasculature, of the tumor was clearly apparent on all 
images of the tumor (Figure 2).
Enhancement persisted for several hours post-injec-
tion (Figure 3). Even at four hours post-injection, the 
tumor signal remained high, especially in comparison 
to the signal in normal musculature. Figure 4 shows the 
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480 mm 520 mm
X-ray tube
Figure 1 Placement of the animal in the micro-cT gantry.
Abbreviations: ccD, charge-coupled device; cT, computed tomography; ecg, electrocardiograph.
Figure 2 Three tomographic images of an R3230Ac tumor in a rat. enhancement is clearly visible.International Journal of Nanomedicine 2009:4 280
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tumor enhancement at 1.2 and 4.2 hours after injection. 
The findings show the continued presence of the 
nanoparticle contrast agent in the blood pool at four hours 
post-injection.
Discussion and conclusions
Comparison between the micro-CT images and corre-
sponding histological sections allows for interpretation of 
the imaging findings (Figure 5). Blood vessels are present 
on histological sections in the same areas where contrast 
enhancement is noted on the CT images. Moreover, evalu-
ation of two typical regions of the tumor, a central slice 
through the core of the mass, and a peripheral slice along 
the capsular margin yield additional insight. A region of 
central necrosis (pink-staining on histological section) is 
readily evident on the central section and corresponds to 
region of subtle hypodensity on the corresponding CT image 
(Figures 5a–c). This finding is in keeping with the known 
behaviour of liposomes which circulate within the bloodpool 
without significant extravasation. Therefore, enhancement 
would only be expected within the viable (purple-staining 
portions) of the mass. On the peripheral section, blood ves-
sel proliferation is demonstrated along the margins of the 
tumor on histological section and correspond to peripheral 
enhancement of the tumor.
The findings demonstrate the utility of the nanoparticle 
contrast agent for imaging angiogenesis in breast cancer. 
The agent enabled an attenuation difference between the 
tumor vasculature and the muscle of 326 ± 151 HU, allowing 
visualization of the 3D vascular architecture. This level of 
attenuation difference also enables estimations of tumor 
volumes and vascular percentages. As vascular enhancement 
was observed at four hours post-injection, its residence time 
in the blood pool was at least four hours. This was signifi-
cantly longer enhancement, on the order of hours, compared 
to traditional, non-encapsulated contrast agents. In addition, 
the liposomal envelope shields the body contrast agent, 
resulting in elimination via the liver and spleen rather than 
excretion via the kidneys.
Several other liposomal-based agents have been 
utilized. Liposomes encapsulating both iodine-based 
and gadolinium-based molecules have been developed 
for multimodality imaging using CT and MRI.16,17 
These agents were prepared with a diluted starting 
iodine solution to incorporate the gadolinium-chelates, 
thus resulting in low iodine concentration within each 
liposome. Prior studies have not focused on breast 
cancer cell lines as a precursor for human applications. 
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Figure 3 Image value (in hU) at two time points for the tumor vasculature and normal 
tissue. Error bars reflect the standard deviation of the values within the ROI.
Abbreviations: hU, Hounsfield units; ROI, region of interest.
Figure 4 Persistent enhancement of the tumor of a rodent several hours after contrast injection of a rodent with liposomal contrast.   These two images were acquired 
1.2 hours (left) and 4.2 hours (right) after contrast injection.   The images reflect positioning differences between two acquisitions.International Journal of Nanomedicine 2009:4 281
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Liposomes containing iodine conjugated to the lipids 
have also been developed.18 The conjugation of iodine 
to lipid results in low iodine:liposome ratio compared 
to our formulation, wherein the iodinated molecules are 
encapsulated within the core interior. Although not used 
in this study, liposomes with an even higher concentra-
tion of iodine (eg, 100 mg/ml) have been successfully 
used.10 Increases in iodine concentration in combination 
with a diffusion-optimized size for the liposomes would 
allow for even better visualization of tumors in small 
animals and may open the door to delayed micro-CT 
imaging studies to examine tumor leakage via contrast 
agent extravasation.
While these findings are qualitative, due to the pilot 
nature of the study, they suggest that a liposomal, nanopar-
ticle contrast agent is a promising tool for micro-CT 
evaluation of tumor vascular architecture in small animals. 
As such, this approach may be useful for the study of tumor 
angiogenesis including the evaluation of antiangiogenic 
therapies in small animals with potential extensions and 
applications to human imaging. The findings pave the 
way for a future more extensive study with a larger cohort 
of animals to provide statistically justified quantitative 
results.
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Figure 5 Micro-CT images and micrographs of histological sections of the same R3230AC tumor implanted in a rat. For a central section of the tumor, this figure shows the 
cT image   A) the corresponding histological section micrograph (low-power) B) and a high-power micrograph of the region contained within the box C). Focal enhancement 
demonstrated on the micro-cT image corresponds to a cluster of blood vessels in corresponding region of the histological section. For a peripheral region of the tumor, 
this figure shows the CT image D) the histological section (low-power micrograph) E) and a high-power micrograph of the region contained within the box F). In this slice, 
enhancement of the rim of the tumor is demonstrated.    The corresponding region of the histological section demonstrates significant blood vessel growth.    While the CT and 
pathology findings cannot be correlated quantitatively, they show similar qualitative indications.
Abbreviation: cT, computed tomography.International Journal of Nanomedicine 2009:4
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